Erlotinib Unknown Status Phase 2 Trials for Metastatic Colorectal Cancers Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00784667Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib